Posts by Sandra Ansanay-Alex
FluoSphera is awarded a CHF 1.1 million grant from Innosuisse
FluoSphera S.A., a biotechnology company developing versatile and disruptive in-vitro solutions for drug discovery to predict drug efficacy and safety under systemic conditions, today announced that its new innovation project together with EPFL and the University of Geneva (UNIGE) has been awarded a grant of CHF 1,100,000 Swiss francs from Innosuisse, the Swiss Innovation Agency.…
Read MoreMaven Health, NeoSens and NADUP supported by the FIT
Three life science projects have received support from the Foundation for Technological Innovation (FIT) in the form of Tech Grants: Maven Health and NeoSens from EPFL, and NADUP from UNIL will be able to continue developing their technologies with the backing of the Foundation. Maven Health – prevention and screening of metabolic diseases…
Read MoreFIT loans CHF 500,000 to Doppl and CHF 100,000 to Rea Diagnostics
DOPPL, a leader in organoid engineering for disease modelling and personalised medicine, has received a Tech Growth loan of CHF 500,000 from the Foundation for Technological Innovation (FIT), while Rea Diagnostics, specialising in the detection of premature births, has received a Tech Seed loan of CHF 100,000. DOPPL, organoids for the future of…
Read MoreBabies prefer human voices
The brains of 4-month-old babies respond preferentially to the human voice over sounds from their environment. This is confirmed by the results of a joint study conducted by a Sense-affiliated researcher from HES-SO Valais-Wallis. These data shed new light on the innate social nature of human beings. The voice is the most important sound…
Read MoreKickfund Ventures: CHF 70 Million for Swiss deeptech startups
The fund, backed by a diverse group of investors, including anchor investors Ernst Göhner Stiftung and Gebert Rüf Stiftung, will provide up to CHF 850,000 per company to Venture Kick alumni. Qualified investors might still be accepted to the partnership. The unique concept of the Kickfund is based on many years of experience and successful…
Read MoreGeneva Digital Health Day
The Geneva Digital Health Day is taking place on 21 May 2026 at Campus Biotech The Geneva Digital Health Day (GDHD) is a unique international conference that brings together healthcare professionals, innovators, implementers, policymakers, and academic leaders who are committed to shaping the future of Digital Health. The GDHD serves as a forward-looking platform…
Read MoreFIT – Fondation pour l’Innovation Technologique
The Foundation for Technological Innovation offers grants and loans to support the development of innovative technological projects at various stages of their evolution. FIT supports projects in the fields of energy & environment, precision industries, nutrition & food technologies, life sciences & health, and information & digital technologies. Since 1994, more than 350…
Read MorePrix Entreprendre Lausanne Région (PERL)
Over the years, the Prix Entreprendre Lausanne Région (PERL) has become a central element of Lausanne Région’s support for companies based in its member municipalities. The competition helps to create and maintain jobs in the Lausanne region. Apply before 9 January 2026! PERL awards Lausanne Région officially opens the 24th edition of the PERL…
Read MoreGENILEM
Since 1995, GENILEM helps entrepreneurs in Vaud and Geneva to build innovative and responsible businesses GENILEM supports innovative entrepreneurs, helping them to overcome today’s challenges and create sustainable solutions for tomorrow’s society. The association offers them advice, training, coaching and access to a network to increase their chances of start-up success. Founded in 1995…
Read MoreConferences
BioAlps is a partner of numerous events throughout the year and can set up events within the events, conferences, or help you identify speakers and experts. Connect in Pharma Connect in Pharma took place from 14 to 15 June 2023 in Palexpo Geneva. BioAlps organised a session on How can AI support patients…
Read More